Lifecore Biomedical
Develops and manufactures sterile injectable products and pharmaceutical-grade hyaluronic acid.
$4.54
After-hours close+0.00 (+0.11%)
At close$4.54(−0.11%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 67.99%25.50M sharesInsiders 6.17%2.31M sharesOther 25.84%9.69M shares
Shares outstanding 37.51M · Float 33.87M · 90.3% free float
Institutions13F, as of Jun 30, 2026
104 holders · 25.50M shares · 17 new positions · 55 increased · 21 reduced · 20 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Wynnefield Capital Inc | 4.70M | 12.54% | 0 | Aug 14, 2026 |
| Legion Partners Asset Management, LLC | 4.46M | 11.90% | 0 | Aug 14, 2026 |
| Greenhaven Road Investment Management, L.P. | 3.19M | 8.51% | −346.8K | Aug 14, 2026 |
| 325 Capital LLC | 2.90M | 7.72% | +733.4K | Aug 14, 2026 |
| BlackRock, Inc. | 2.01M | 5.37% | +135.8K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 1.29M | 3.44% | −1.5K | Aug 13, 2026 |
| Geode Capital Management, LLC | 855.5K | 2.28% | +40.4K | Aug 12, 2026 |
| Morgan Stanley | 769.4K | 2.05% | +4.6K | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Legion Partners Holdings, LLCincl. White Raymond T., Legion Partners, L.P. I +4 more | 17.10% | 6.79M | 13D | Jul 2, 2026 ↗ |
| Greenhaven Road Investment Management, L.P. | 9.80% | 3.62M | 13G | Feb 14, 2025 ↗ |
| 22NW GP, Inc.incl. Aron R. English, Bryson O. Hirai-Hadley +4 more | 6.74% | 2.71M | 13D | Jul 2, 2026 ↗ |
| BlackRock, Inc. | 5.40% | 2.01M | 13G | Jul 29, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Paul Josephs | director, officer: Chief Executive Officer | 592.9K | 1.58% | May 21, 2026 |
| Christopher S. Kiper | director, 10 percent owner: | 422.8K | 1.13% | Jun 8, 2026 |
| Ryan David Lake | officer: Chief Financial Officer | 336.7K | 0.90% | Sep 4, 2025 |
| English Aron R. | 10 percent owner | 264.2K | 0.70% | May 28, 2025 |
| Thomas D. Salus | officer: Chief Legal & Administration | 246.3K | 0.66% | Apr 16, 2026 |
| Nelson Obus | director | 164.1K | 0.44% | Jun 5, 2026 |
| Lovas Katrina Houde | director | 135.3K | 0.36% | Jun 5, 2026 |
| Joshua Schechter | director | 133.1K | 0.35% | Jun 5, 2026 |
| Humberto Calheiros Antunes | director | 73.0K | 0.19% | Jun 5, 2026 |
| Jason Aryeh | director | 70.0K | 0.19% | Jun 5, 2026 |
2 ten-percent owners hold 4.97M shares by Form 4, outside the officers-and-directors figure above · 6 people have not refiled in the last 18 months (622.5K shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.